HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antiviral drugs in the immunocompetent host: part II. Treatment of influenza and respiratory syncytial virus infections.

Abstract
Family physicians should be familiar with the various drugs available for treating and preventing viral infections. Part II of this two-part article focuses on agents used to manage influenza and respiratory syncytial virus. Rimantadine and amantadine traditionally have been used to prevent and treat influenza type A infections. The neuraminidase inhibitors zanamivir and oseltamivir have a broadened spectrum of activity in the treatment and prevention of influenza types A and B. Ribavirin has been used in some high-risk infants to treat respiratory syncytial virus infections, and palivizumab can be used for prophylaxis.
AuthorsRichard Colgan, Robert Michocki, Lisa Greisman, Tracy A Wolff Moore
JournalAmerican family physician (Am Fam Physician) Vol. 67 Issue 4 Pg. 763-6, 675 (Feb 15 2003) ISSN: 0002-838X [Print] United States
PMID12613730 (Publication Type: Journal Article, Review)
Chemical References
  • Antiviral Agents
Topics
  • Antiviral Agents (therapeutic use)
  • Humans
  • Immunocompetence
  • Influenza, Human (drug therapy)
  • Respiratory Syncytial Virus Infections (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: